Clinical Outcomes With Metformin and Sulfonylurea Therapies Among Patients With Heart Failure and Diabetes
Muhammad Shahzeb Khan
1
,
Nicole Solomon
2
,
Adam D. DeVore
1, 2
,
Abhinav Sharma
3
,
G. Michael Felker
1, 2
,
Adrian F. Hernandez
1, 2
,
Paul A. Heidenreich
4
,
Roland A. Matsouaka
2, 5
,
Jennifer B Green
2, 6
,
Javed Butler
7
,
Clyde W. Yancy
8
,
Pamela N. Peterson
9, 10
,
Gregg C. Fonarow
11
,
Stephen J. Greene
1, 2
2
Duke Clinical Research Institute, Durham, North Carolina, USA
|
4
Department of Medicine, Veterans Affairs Palo Alto Health Care System, Palo Alto, California, USA
|
10
Division of Cardiology, Denver Health Medical Center, Denver, Colorado, USA
|
Publication type: Journal Article
Publication date: 2022-03-01
scimago Q1
wos Q1
SJR: 5.218
CiteScore: 16.6
Impact factor: 11.8
ISSN: 22131779, 22131787
PubMed ID:
34895861
Cardiology and Cardiovascular Medicine
Abstract
The authors sought to characterize associations between initiation of metformin and sulfonylurea therapy and clinical outcomes among patients with comorbid heart failure (HF) and diabetes (overall and by ejection fraction [EF] phenotype).
Found
Nothing found, try to update filter.
Found
Nothing found, try to update filter.
Top-30
Journals
|
1
2
|
|
|
Die Diabetologie
2 publications, 8%
|
|
|
Journal of the American Heart Association
1 publication, 4%
|
|
|
Journal of Clinical Medicine
1 publication, 4%
|
|
|
Frontiers in Cardiovascular Medicine
1 publication, 4%
|
|
|
Archives of Pharmacal Research
1 publication, 4%
|
|
|
Expert Opinion on Investigational Drugs
1 publication, 4%
|
|
|
Life
1 publication, 4%
|
|
|
Diabetology and Metabolic Syndrome
1 publication, 4%
|
|
|
Expert Opinion on Pharmacotherapy
1 publication, 4%
|
|
|
Journal of Cardiovascular Translational Research
1 publication, 4%
|
|
|
Cardiology
1 publication, 4%
|
|
|
Diabetes and Metabolism
1 publication, 4%
|
|
|
Cardiac Failure Review
1 publication, 4%
|
|
|
Experimental and Clinical Endocrinology and Diabetes
1 publication, 4%
|
|
|
International Journal of Molecular Sciences
1 publication, 4%
|
|
|
Clinical Pharmacology in Drug Development
1 publication, 4%
|
|
|
Biomedicines
1 publication, 4%
|
|
|
Diabetes, Obesity and Metabolism
1 publication, 4%
|
|
|
Journal of Investigative Medicine
1 publication, 4%
|
|
|
PLoS ONE
1 publication, 4%
|
|
|
Current Bioactive Compounds
1 publication, 4%
|
|
|
Minerva Medica
1 publication, 4%
|
|
|
Current Issues in Molecular Biology
1 publication, 4%
|
|
|
1
2
|
Publishers
|
1
2
3
4
5
|
|
|
MDPI
5 publications, 20%
|
|
|
Springer Nature
4 publications, 16%
|
|
|
Wiley
3 publications, 12%
|
|
|
Taylor & Francis
2 publications, 8%
|
|
|
Frontiers Media S.A.
1 publication, 4%
|
|
|
Pharmaceutical Society of Korea
1 publication, 4%
|
|
|
S. Karger AG
1 publication, 4%
|
|
|
Elsevier
1 publication, 4%
|
|
|
Radcliffe Media Media Ltd
1 publication, 4%
|
|
|
Georg Thieme Verlag KG
1 publication, 4%
|
|
|
SAGE
1 publication, 4%
|
|
|
Public Library of Science (PLoS)
1 publication, 4%
|
|
|
Bentham Science Publishers Ltd.
1 publication, 4%
|
|
|
Edizioni Minerva Medica
1 publication, 4%
|
|
|
1
2
3
4
5
|
- We do not take into account publications without a DOI.
- Statistics recalculated weekly.
Are you a researcher?
Create a profile to get free access to personal recommendations for colleagues and new articles.
Metrics
25
Total citations:
25
Citations from 2024:
12
(48%)
Cite this
GOST |
RIS |
BibTex |
MLA
Cite this
GOST
Copy
Khan M. S. et al. Clinical Outcomes With Metformin and Sulfonylurea Therapies Among Patients With Heart Failure and Diabetes // JACC: Heart Failure. 2022. Vol. 10. No. 3. pp. 198-210.
GOST all authors (up to 50)
Copy
Khan M. S., Solomon N., DeVore A. D., Sharma A., Felker G. M., Hernandez A. F., Heidenreich P. A., Matsouaka R. A., Green J. B., Butler J., Yancy C. W., Peterson P. N., Fonarow G. C., Greene S. J. Clinical Outcomes With Metformin and Sulfonylurea Therapies Among Patients With Heart Failure and Diabetes // JACC: Heart Failure. 2022. Vol. 10. No. 3. pp. 198-210.
Cite this
RIS
Copy
TY - JOUR
DO - 10.1016/j.jchf.2021.11.001
UR - https://doi.org/10.1016/j.jchf.2021.11.001
TI - Clinical Outcomes With Metformin and Sulfonylurea Therapies Among Patients With Heart Failure and Diabetes
T2 - JACC: Heart Failure
AU - Khan, Muhammad Shahzeb
AU - Solomon, Nicole
AU - DeVore, Adam D.
AU - Sharma, Abhinav
AU - Felker, G. Michael
AU - Hernandez, Adrian F.
AU - Heidenreich, Paul A.
AU - Matsouaka, Roland A.
AU - Green, Jennifer B
AU - Butler, Javed
AU - Yancy, Clyde W.
AU - Peterson, Pamela N.
AU - Fonarow, Gregg C.
AU - Greene, Stephen J.
PY - 2022
DA - 2022/03/01
PB - Elsevier
SP - 198-210
IS - 3
VL - 10
PMID - 34895861
SN - 2213-1779
SN - 2213-1787
ER -
Cite this
BibTex (up to 50 authors)
Copy
@article{2022_Khan,
author = {Muhammad Shahzeb Khan and Nicole Solomon and Adam D. DeVore and Abhinav Sharma and G. Michael Felker and Adrian F. Hernandez and Paul A. Heidenreich and Roland A. Matsouaka and Jennifer B Green and Javed Butler and Clyde W. Yancy and Pamela N. Peterson and Gregg C. Fonarow and Stephen J. Greene},
title = {Clinical Outcomes With Metformin and Sulfonylurea Therapies Among Patients With Heart Failure and Diabetes},
journal = {JACC: Heart Failure},
year = {2022},
volume = {10},
publisher = {Elsevier},
month = {mar},
url = {https://doi.org/10.1016/j.jchf.2021.11.001},
number = {3},
pages = {198--210},
doi = {10.1016/j.jchf.2021.11.001}
}
Cite this
MLA
Copy
Khan, Muhammad Shahzeb, et al. “Clinical Outcomes With Metformin and Sulfonylurea Therapies Among Patients With Heart Failure and Diabetes.” JACC: Heart Failure, vol. 10, no. 3, Mar. 2022, pp. 198-210. https://doi.org/10.1016/j.jchf.2021.11.001.